Executive Advisory Case Studies
See how connected MedTech exposure becomes a clearer executive decision.
Five anonymized examples showing how regulatory, clinical, quality, portfolio, and commercial signals can be brought into one defensible decision picture.
Each example is based on Dr. Shola Sulaimon’s prior MedTech leadership and advisory experience. Company, product, timing, and operational details have been generalized to protect confidentiality.
The SHOTUNE Decision Lens
The technical issue is only the starting point.
These examples show how SHOTUNE examines the decision under pressure, the connected exposure, the evidence and functions involved, the consequences leadership must consider, and the action required to move forward with a more defensible position.
01
Portfolio Risk
Building One Decision Picture Before Staggered EU Market-Access Decisions
How evidence maturity, resource capacity, certification timing, and commercial exposure were brought together so leadership could evaluate a mixed portfolio as one connected decision.
02
Notified Body Response
Closing a Notified Body Deficiency Response Without Creating New Inconsistencies
How the CER, PMCF, PMS, risk-management file, SSCP, claims, and technical documentation were examined as one response position instead of separate corrective tasks.
03
Commercialization Risk
Finding Commercialization Risk Inside a Clinical Evidence Position
How the evidence position was pressure-tested against intended purpose, claims, regulatory pathway, timing, and commercial commitments before additional investment moved forward.
04
PMCF Strategy
Turning PMCF Into a Portfolio and Commercialization Tool
How PMCF activities were connected to defined uncertainty, leadership decisions, success criteria, and future certification needs rather than treated as isolated obligations.
05
Legacy Device MDR Readiness
Rebuilding Clinical Evaluation Logic Under Current EU MDR Expectations
How long market history, current claims, state of the art, PMS, PMCF, and risk conclusions were tested to determine whether the evidence architecture remained supportable.
Read the Complete Collection
Review the decision context behind all five case studies.
The full collection examines the exposure, executive stakes, connected evidence, SHOTUNE decision lens, and recommended point of engagement for each example.
Confidential Executive Advisory
Does one technical issue appear to be creating wider business exposure?
Bring the product, deadline, regulator response, evidence concern, open finding, or portfolio decision. The first conversation is used to clarify the decision under pressure, the connected exposure, and whether SHOTUNE is the right fit.